Showing 1 - 20 results of 229,323 for search '(( 50 ((nn decrease) OR (_ decrease)) ) OR ((( _ a decrease ) OR ( end point decrease ))))*', query time: 1.14s Refine Results
  1. 1

    PowerPoint Slides for: Patiromer Decreases Serum Potassium and Phosphate Levels in Patients on Hemodialysis by Bushinsky D.A. (3246690)

    Published 2016
    “…The effect of patiromer, a gastrointestinal K binder, on serum K was examined in HD patients. …”
  2. 2
  3. 3
  4. 4
  5. 5

    NatB inactivation decreased the level of MAPK and proposed model of EGFR/MAPK signaling regulation by NatB and the N-end rule pathways. by Zhentao Sheng (107495)

    Published 2020
    “…<p>(A-B) <i>psid-D1</i> (A) or <i>psid-D4</i> (B) clones in 3rd instar fat body, which were marked by GFP expression (pointed by arrowheads), showed decreased MAPK levels (anti-MAPK staining, red). …”
  6. 6

    Variable importance plot (mean decrease accuracy and mean decrease Gini). by Fernando Martinez-Taboada (8655132)

    Published 2020
    “…The variables are presented from descending importance. The mean decrease in Gini coefficient is a measure of how each variable contributes to the homogeneity of the nodes and leaves in the resulting random forest. …”
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Decreased oscillatory flow decreases <i>klf2a</i> expression. by Julien Vermot (257990)

    Published 2009
    “…<p>(A) RFF is decreased by alterations in heart rate. …”
  13. 13

    NatB-inactivation decreased Drk levels through its N-terminal sequences, which was regulated by the N-end rule E3 ubiquitin ligase POE/UBR4. by Zhentao Sheng (107495)

    Published 2020
    “…<i>psid-D4</i> mutant clones (B) show similar levels of β-gal but decreased level of N-Drk-GFP in comparison to FRT control (A). …”
  14. 14

    Decreased macrophage recruitment correlates with decreased angiogenesis. by Johanna R. Reed (306158)

    Published 2013
    “…<p>A) Quantification of BrdU incorporation demonstrates that decreased macrophage infiltration does not significantly correlate with a change in epithelial cell proliferation (N.S. = not significant). …”
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
  20. 20